| 000 | 01017 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515062213.0 | ||
| 264 | 0 | _c20070614 | |
| 008 | 200706s 0 0 eng d | ||
| 022 | _a1699-3993 | ||
| 024 | 7 |
_a10.1358/dot.2007.43.3.1067345 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKakar, Puneet | |
| 245 | 0 | 0 |
_aRivaroxaban. _h[electronic resource] |
| 260 |
_bDrugs of today (Barcelona, Spain : 1998) _cMar 2007 |
||
| 300 |
_a129-36 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMorpholines _xadverse effects |
| 650 | 0 | 4 | _aRivaroxaban |
| 650 | 0 | 4 |
_aThiophenes _xadverse effects |
| 700 | 1 | _aWatson, Timothy | |
| 700 | 1 | _aLip, Gregory Y H | |
| 773 | 0 |
_tDrugs of today (Barcelona, Spain : 1998) _gvol. 43 _gno. 3 _gp. 129-36 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1358/dot.2007.43.3.1067345 _zAvailable from publisher's website |
| 999 |
_c16934800 _d16934800 |
||